A data driven policy to minimise the tuberculosis testing cost among healthcare workers
- PMID: 35527355
- PMCID: PMC9541762
- DOI: 10.1002/hpm.3496
A data driven policy to minimise the tuberculosis testing cost among healthcare workers
Abstract
Introduction: The Centres for Disease Control and Prevention (CDC) mandates that healthcare employees at high-risk exposure to Tuberculosis (TB) undergo annual testing. Currently, two methods of TB testing are used: a two-step skin test (TST) or a whole-blood test (IGRA). Healthcare leadership's test selection must account for not only direct costs such as procedure and resources but also indirect costs, including employee workplace absence.
Methods: A mathematical model based on Upstate South Carolina's largest health system affecting over 18,000 employees on six campuses was developed to investigate the value loss perspective of these testing methods and assist in decision-making. A process flow map identified the varied direct and indirect costs for each test for four employee types, and 6 travel-to-testing-site times were calculated.
Results: The switching point between testing procedures that minimised total system costs was most influenced by employee salary compared to travel distance. Switching from the current hospital policy to an integrated TST/IGRA testing could reduce TB compliance costs by 28%.
Conclusions: This study recommends an integrated approach as cost-effective for large health systems with multiple campuses while considering the direct and indirect costs. When accounting for 'inconvenience costs' (stress, etc.) associated with visits, IGRAs are recommended irrespective of employee salary.
Keywords: cost analysis; decision-making; healthcare policy; mathematical modelling; tuberculosis testing.
© 2022 The Authors. The International Journal of Health Planning and Management published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.Pulmonology. 2021 Nov-Dec;27(6):493-499. doi: 10.1016/j.pulmoe.2021.04.002. Epub 2021 May 27. Pulmonology. 2021. PMID: 34053903 Review.
-
Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.BMC Pulm Med. 2010 Feb 22;10:7. doi: 10.1186/1471-2466-10-7. BMC Pulm Med. 2010. PMID: 20170555 Free PMC article.
-
Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.BMC Med. 2017 May 17;15(1):104. doi: 10.1186/s12916-017-0865-x. BMC Med. 2017. PMID: 28514962 Free PMC article.
-
Screening health care workers with interferon-γ release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study).J Occup Environ Med. 2012 Jul;54(7):806-15. doi: 10.1097/JOM.0b013e318254620f. J Occup Environ Med. 2012. PMID: 22796924
-
IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.Expert Rev Anti Infect Ther. 2013 Jan;11(1):37-48. doi: 10.1586/eri.12.150. Expert Rev Anti Infect Ther. 2013. PMID: 23428101 Review.
References
-
- Rich AR. The Pathogenesis of Tuberculosis: C. C. Thomas; 1946.
-
- World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection: WHO; 2015. - PubMed
-
- Institute of Medicine . Tuberculosis in the Workplace: National Academies Press; 2001. - PubMed
-
- Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health‐care settings. MMWR Recomm Rep. 2005;54(17):1‐141. Accessed July 21, 2020. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5417a1.htm - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical